156 related articles for article (PubMed ID: 22974315)
21. Differential outcomes in prediabetic vs. overtly diabetic NOD mice nonmyeloablatively conditioned with costimulatory blockade.
Bozulic LD; Huang Y; Xu H; Wen Y; Ildstad ST
Exp Hematol; 2011 Oct; 39(10):977-85. PubMed ID: 21726515
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
23. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice.
Li H; Kaufman CL; Ildstad ST
Surgery; 1995 Aug; 118(2):192-7; discussion 197-8. PubMed ID: 7638733
[TBL] [Abstract][Full Text] [Related]
24. Partial versus full allogeneic hemopoietic chimerization is a preferential means to inhibit type 1 diabetes as the latter induces generalized immunosuppression.
Serreze DV; Osborne MA; Chen YG; Chapman HD; Pearson T; Brehm MA; Greiner DL
J Immunol; 2006 Nov; 177(10):6675-84. PubMed ID: 17082580
[TBL] [Abstract][Full Text] [Related]
25. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
27. Patterns of hemopoietic reconstitution in nonobese diabetic mice: dichotomy of allogeneic resistance versus competitive advantage of disease-resistant marrow.
Kaufman CL; Li H; Ildstad ST
J Immunol; 1997 Mar; 158(5):2435-42. PubMed ID: 9036994
[TBL] [Abstract][Full Text] [Related]
28. Mixed chimerism and split tolerance: mechanisms and clinical correlations.
Al-Adra DP; Anderson CC
Chimerism; 2011; 2(4):89-101. PubMed ID: 22509425
[TBL] [Abstract][Full Text] [Related]
29. Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD mice.
Racine JJ; Wang M; Zhang M; Zeng D
Diabetes; 2014 Jun; 63(6):2051-62. PubMed ID: 24458357
[TBL] [Abstract][Full Text] [Related]
30. Non-myeloablative mixed chimerism approaches and tolerance, a split decision.
Luo B; Chan WF; Shapiro AM; Anderson CC
Eur J Immunol; 2007 May; 37(5):1233-42. PubMed ID: 17390394
[TBL] [Abstract][Full Text] [Related]
31. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.
Xu H; Chilton PM; Huang Y; Schanie CL; Ildstad ST
J Immunol; 2004 Feb; 172(3):1463-71. PubMed ID: 14734723
[TBL] [Abstract][Full Text] [Related]
32. Induction of tolerance across fully mismatched barriers by a nonmyeloablative treatment excluding antibodies or irradiation use.
Stephan L; Pichavant C; Bouchentouf M; Mills P; Camirand G; Tagmouti S; Rothstein D; Tremblay JP
Cell Transplant; 2006; 15(8-9):835-46. PubMed ID: 17269453
[TBL] [Abstract][Full Text] [Related]
33. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
34. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
35. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
Elkin G; Prigozhina TB; Slavin S
Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
[TBL] [Abstract][Full Text] [Related]
36. Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells.
Tian C; Bagley J; Iacomini J
Am J Transplant; 2006 Sep; 6(9):2202-7. PubMed ID: 16827788
[TBL] [Abstract][Full Text] [Related]
37. The requirement for allogeneic chimerism for second transfer of tolerance from mixed allogeneic chimeras (A+B-->A) to secondary recipients.
Wren SM; Hronakes ML; Ildstad ST
Transplantation; 1992 Dec; 54(6):1031-40. PubMed ID: 1465769
[TBL] [Abstract][Full Text] [Related]
38. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
39. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance.
Chen JC; Kuo ML; Ou LS; Chang PY; Muench MO; Shen CR; Chang HL; Yu HY; Fu RH
Cell Transplant; 2010; 19(12):1609-22. PubMed ID: 20719075
[TBL] [Abstract][Full Text] [Related]
40. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
